KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) EBT (2018 - 2025)

Historic EBT for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $24.0 million.

  • Progyny's EBT rose 3341.5% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.2 million, marking a year-over-year increase of 1641.69%. This contributed to the annual value of $83.2 million for FY2024, which is 1769.82% up from last year.
  • Per Progyny's latest filing, its EBT stood at $24.0 million for Q3 2025, which was up 3341.5% from $27.1 million recorded in Q2 2025.
  • Over the past 5 years, Progyny's EBT peaked at $27.1 million during Q2 2025, and registered a low of -$398000.0 during Q4 2021.
  • Over the past 5 years, Progyny's median EBT value was $16.3 million (recorded in 2023), while the average stood at $15.2 million.
  • In the last 5 years, Progyny's EBT plummeted by 13384.35% in 2021 and then soared by 1160070.42% in 2023.
  • Over the past 5 years, Progyny's EBT (Quarter) stood at -$398000.0 in 2021, then soared by 1140.45% to $4.1 million in 2022, then skyrocketed by 292.71% to $16.3 million in 2023, then increased by 8.58% to $17.7 million in 2024, then skyrocketed by 35.71% to $24.0 million in 2025.
  • Its last three reported values are $24.0 million in Q3 2025, $27.1 million for Q2 2025, and $26.5 million during Q1 2025.